• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于创建可控性贮尿囊通道的技术:儿童长期结果比较

Techniques Used to Create Continent Catheterizable Channels: A Comparison of Long-term Results in Children.

作者信息

Polm Pepijn D, de Kort Laetitia M O, de Jong Tom P V M, Dik Pieter

机构信息

Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands.

Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands.

出版信息

Urology. 2017 Dec;110:192-195. doi: 10.1016/j.urology.2017.08.030. Epub 2017 Aug 31.

DOI:10.1016/j.urology.2017.08.030
PMID:28864341
Abstract

OBJECTIVE

To compare long-term results of 3 different techniques used to create continent catheterizable channels (CCCs) in children in a single institution.

PATIENTS AND METHODS

Data were retrospectively collected from 112 children who had a CCC (appendicovesicostomy [APV], tubularized bladder flap [TBF] or Monti) created between December 1995 and December 2013. Primary outcome was revision-free survival. Secondary outcomes were channel stenosis, incontinence, and false channel requiring revision. Time-to-event survival was analyzed using a Kaplan-Meier survival curve.

RESULTS

A total of 117 CCCs were identified with median follow-up of 85 months. Surgical revision was required in 52%, with no significant difference between the different techniques. Major revision was required in 27% of the cases and significantly more often in Monti channels. Complete revision was required in 7%. Stenosis requiring revision was seen in 33%. A false channel was formed in 9% of the cases. Incontinence with a low leak point pressure was seen in 12%. A time-to-event analysis with a Kaplan-Meier curve showed no significant differences between the 3 techniques.

CONCLUSION

Although CCC is an effective solution for children who cannot perform urethral catheterization, 52% requires surgical revision. Because no differences were found in outcome between APV, TBF, and Monti, we conclude that a TBF CCC is a good alternative for the APV. If the appendix is not available and bladder volume is sufficient, a TBF channel is preferred to a Monti channel.

摘要

目的

比较在单一机构中用于为儿童创建可控性尿流改道通道(CCC)的3种不同技术的长期效果。

患者与方法

回顾性收集了1995年12月至2013年12月期间接受CCC(阑尾膀胱造口术[APV]、管状膀胱瓣[TBF]或蒙蒂术)的112例儿童的数据。主要结局是无翻修生存率。次要结局是通道狭窄、尿失禁以及需要翻修的假通道。采用Kaplan-Meier生存曲线分析事件发生时间生存率。

结果

共识别出117条CCC,中位随访时间为85个月。52%的患者需要手术翻修,不同技术之间无显著差异。27%的病例需要进行重大翻修,蒙蒂通道的翻修频率明显更高。7%的病例需要完全翻修。33%的病例出现需要翻修的狭窄。9%的病例形成了假通道。12%的病例出现低漏点压力性尿失禁。采用Kaplan-Meier曲线进行的事件发生时间分析显示,3种技术之间无显著差异。

结论

尽管CCC对于无法进行尿道插管的儿童是一种有效的解决方案,但52%的患者需要手术翻修。由于APV、TBF和蒙蒂术在结局上未发现差异,我们得出结论,TBF CCC是APV的一个良好替代方案。如果没有阑尾且膀胱容量足够,TBF通道比蒙蒂通道更可取。

相似文献

1
Techniques Used to Create Continent Catheterizable Channels: A Comparison of Long-term Results in Children.用于创建可控性贮尿囊通道的技术:儿童长期结果比较
Urology. 2017 Dec;110:192-195. doi: 10.1016/j.urology.2017.08.030. Epub 2017 Aug 31.
2
Long-term outcomes of catheterizable continent urinary channels: What do you use, where you put it, and does it matter?可控性尿流改道的长期预后:你使用什么、将其置于何处以及这重要吗?
J Pediatr Urol. 2015 Aug;11(4):210.e1-7. doi: 10.1016/j.jpurol.2015.05.002. Epub 2015 May 30.
3
Continent catheterizable urinary channels: Lessons for lifelong urological care from a comparative analysis of very long-term complications and revision-free survival of three different types. continent 可控性尿流通道:三种不同类型的长期并发症和无翻修生存率的比较分析对终身泌尿外科护理的启示。
Neurourol Urodyn. 2024 Jun;43(5):1083-1089. doi: 10.1002/nau.25350. Epub 2023 Dec 11.
4
Do anterior catheterizable urinary channels have fewer complications than posterior channels? An international cohort study.经前入路的可导尿尿路通道并发症是否比经后入路的少?一项国际队列研究。
J Pediatr Urol. 2018 Feb;14(1):48.e1-48.e7. doi: 10.1016/j.jpurol.2017.06.020. Epub 2017 Aug 2.
5
Split appendix Mitrofanoffs have higher risk of complication than intact appendix or monti channels.分体阑尾比完整阑尾或蒙蒂通道具有更高的并发症风险。
J Pediatr Urol. 2021 Oct;17(5):700.e1-700.e6. doi: 10.1016/j.jpurol.2021.06.002. Epub 2021 Jun 6.
6
A comparison of the Monti and spiral Monti procedures: A long-term analysis.蒙蒂术式与螺旋蒙蒂术式的比较:长期分析
J Pediatr Urol. 2015 Jun;11(3):134.e1-6. doi: 10.1016/j.jpurol.2014.12.013. Epub 2015 Mar 25.
7
Outcomes according to channel type for continent catheterizable channels in patients undergoing simultaneous urinary and fecal reconstruction.同时进行尿便重建的患者中,应用可控性膀胱通道类型的结果。
J Pediatr Surg. 2021 Aug;56(8):1335-1341. doi: 10.1016/j.jpedsurg.2020.11.002. Epub 2020 Nov 13.
8
Tubularized Bladder Flap as a Continent Catheterizable Channel in Adults.管状膀胱皮瓣作为成人的 continent 导管通道。
Urology. 2024 May;187:140-146. doi: 10.1016/j.urology.2024.03.017. Epub 2024 Mar 11.
9
Continent Cutaneous Catheterizable Channels in Pediatric Patients: A Decade of Experience with Open and Robotic Approaches in a Single Center.小儿患者的经皮可插管通道:单中心 10 年开放和机器人手术经验
Eur Urol. 2021 Jun;79(6):866-878. doi: 10.1016/j.eururo.2020.08.013. Epub 2020 Aug 28.
10
Effect of baseline obesity and postoperative weight gain on the risk of channel revision following continent catheterizable urinary channel surgery.基线肥胖和术后体重增加对可控性尿流改道手术后通道修复风险的影响。
J Pediatr Urol. 2016 Aug;12(4):249.e1-7. doi: 10.1016/j.jpurol.2016.05.021. Epub 2016 Jun 11.

引用本文的文献

1
Mitrofanoff complications: time-to-event analysis of split versus intact appendix and meta-analysis.米氏可控性造瘘术并发症:阑尾劈开与完整阑尾的事件发生时间分析及荟萃分析
World J Urol. 2025 Jan 27;43(1):90. doi: 10.1007/s00345-024-05434-y.
2
Quality of Life in Pediatric Patients with Continent Urinary Diversion-A Single Center Experience.小儿可控性尿流改道术患者的生活质量:单中心经验。
Int J Environ Res Public Health. 2022 Aug 5;19(15):9628. doi: 10.3390/ijerph19159628.
3
Long-term complications of continent catheterizable channels: a problem for transitional urologists.
可控性膀胱造瘘通道的长期并发症:过渡性泌尿外科医生面临的一个问题。
Transl Androl Urol. 2018 Aug;7(4):558-566. doi: 10.21037/tau.2018.03.26.